Literature DB >> 17157596

Analysis of bacterial cultures in infectious keratitis, 1997 to 2004.

David L Yeh1, Sandra S Stinnett, Natalie A Afshari.   

Abstract

PURPOSE: To review bacterial culture results in infectious keratitis at a tertiary referral center.
DESIGN: Retrospective case series.
METHODS: Analysis of Gram stain, bacterial culture, and targeted antibiotic sensitivities of all cases of presumed infectious keratitis at Duke University Eye Center from 1997 to 2004 (n = 453).
RESULTS: Cultures were positive in 307 cases (68%); 21% demonstrated polymicrobial growth. Among 388 isolates, 81% were Gram-positive. Gram stain results were available in 334 cases, demonstrating 18% sensitivity and 94% specificity. Antibiotic sensitivities revealed 24% resistance of tested S. aureus isolates to cefazolin, and <5% resistance of tested gram-negative isolates to various antibiotics, with no statistically significant increase from 1997 to 2004.
CONCLUSIONS: In this study, the microbial profile has remained stable from 1997 to 2004. Gram stain studies were of poor sensitivity, while culture yields were significantly higher and demonstrated a relatively high polymicrobial infection rate. Increasing antibiotic resistance was not clearly demonstrated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17157596     DOI: 10.1016/j.ajo.2006.06.056

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  13 in total

1.  Checks and balances: the ocular response to infection.

Authors:  Michelle C Callegan
Journal:  Virulence       Date:  2010 Jul-Aug       Impact factor: 5.882

2.  Iris melanin pigment as a masquerade of Gram-positive cocci after penetrating ocular trauma.

Authors:  Wenlan Zhang; Alan D Proia; Sumit Sharma; David Fleischman
Journal:  Digit J Ophthalmol       Date:  2018-10-18

Review 3.  Geographic variations in microbial keratitis: an analysis of the peer-reviewed literature.

Authors:  Ameet Shah; Arun Sachdev; David Coggon; Parwez Hossain
Journal:  Br J Ophthalmol       Date:  2011-04-08       Impact factor: 4.638

4.  Contact lens disinfecting solutions antibacterial efficacy: comparison between clinical isolates and the standard ISO ATCC strains of Pseudomonas aeruginosa and Staphylococcus aureus.

Authors:  M Mohammadinia; S Rahmani; G Eslami; M Ghassemi-Broumand; M Aghazadh Amiri; Gh Aghaie; S M Tabatabaee; S Taheri; A Behgozin
Journal:  Eye (Lond)       Date:  2011-11-18       Impact factor: 3.775

Review 5.  Practical Guidance for Clinical Microbiology Laboratories: Diagnosis of Ocular Infections.

Authors:  Sixto M Leal; Kyle G Rodino; W Craig Fowler; Peter H Gilligan
Journal:  Clin Microbiol Rev       Date:  2021-06-02       Impact factor: 50.129

Review 6.  A Systematic Review of Multi-decade Antibiotic Resistance Data for Ocular Bacterial Pathogens in the United States.

Authors:  Paulo J M Bispo; Daniel F Sahm; Penny A Asbell
Journal:  Ophthalmol Ther       Date:  2022-02-03

7.  Clinical features of infectious keratitis at a tertiary referral center in a rural area of Korea.

Authors:  Seung-Jun Lee; Jang Hun Lee; Moosang Kim; Sang Beom Han; Joon Young Hyon
Journal:  Int Med Case Rep J       Date:  2015-12-07

8.  Staphylococcus aureus activates the NLRP3 inflammasome in human and rat conjunctival goblet cells.

Authors:  Victoria E McGilligan; Meredith S Gregory-Ksander; Dayu Li; Jonathan E Moore; Robin R Hodges; Michael S Gilmore; Tara C B Moore; Darlene A Dartt
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

9.  Spectrum and Sensitivity of Bacterial Keratitis Isolates in Auckland.

Authors:  S Marasini; S Swift; S J Dean; S E Ormonde; J P Craig
Journal:  J Ophthalmol       Date:  2016-04-26       Impact factor: 1.909

10.  Infectious keratitis: isolated microbes and their antibiotic susceptibility pattern during 2004-2014 in Region Örebro County, Sweden.

Authors:  Susanna Sagerfors; Birgitta Ejdervik-Lindblad; Bo Söderquist
Journal:  Acta Ophthalmol       Date:  2019-10-03       Impact factor: 3.761

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.